Prognostic significance of tumour markers in Chinese patients with gastric cancer

The clinical value of preoperative tumour markers remains elusive in gastric cancer. The aim of this study was to investigate the prognostic value of alpha‐fetoprotein (AFP), carcinoembryonic antigen (CEA), carbohydrate antigen (CA)19‐9, CA50 and CA72‐4 in gastric cancer.

[1]  C. Huzmeli,et al.  Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer , 2008, Advances in therapy.

[2]  Guang-ye Du,et al.  Clinical significance of changes in tumor markers, extracellular matrix, MMP-9 and VEGF in patients with gastric carcinoma. , 2007, Hepato-gastroenterology.

[3]  S. Natsugoe,et al.  Biological aggressiveness of alpha-fetoprotein (AFP)-positive gastric cancer. , 2006, Hepato-gastroenterology.

[4]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[5]  A. Norman,et al.  Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer--pooled analysis from three multicenter, randomized, controlled trials using individual patient data. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  C. Cass,et al.  Gastric Cancer: Establishing Predictors of Biologic Behavior with Use of Population-Based Data , 2004, Annals of Surgical Oncology.

[7]  T. Saito,et al.  Lymph node metastasis as a significant prognostic factor in gastric cancer: a multiple logistic regression analysis , 2004, Scandinavian journal of gastroenterology.

[8]  S. Kitano,et al.  AFP-Producing Gastric Carcinoma: Multivariate Analysis of Prognostic Factors in 270 Patients , 2003, Oncology.

[9]  E. Cook,et al.  Asian ethnicity-related differences in gastric cancer presentation and outcome among patients treated at a canadian cancer center. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  C. Haglund,et al.  CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers. , 2002, Anticancer research.

[11]  M. Ychou,et al.  Clinical Significance and Prognostic Value of CA72-4 Compared with CEA and CA19-9 in Patients with Gastric Cancer , 2002, Disease markers.

[12]  I. Arribas,et al.  Prognostic Value of Carcinoembryonic Antigen, CA 19-9 and CA 72-4 in Gastric Carcinoma , 2001, Tumor Biology.

[13]  N. Duraker,et al.  The prognostic significance of preoperative serum CA 19‐9 in patients with resectable gastric carcinoma: comparison with CEA , 2001, Journal of surgical oncology.

[14]  M. Fujii,et al.  Evaluation of serum CEA and CA19-9 levels as prognostic factors in patients with gastric cancer , 2000, Gastric Cancer.

[15]  H. Shimada,et al.  Impact of Preoperative Serum Carcinoembryonic Antigen, CA 19-9 and Alpha Fetoprotein Levels in Gastric Cancer Patients , 1998, Tumor Biology.

[16]  A. Ochiai,et al.  c-erbB2 and p53 expression are not associated with stage progression of gastric cancer in Britain or Japan. , 1997, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[17]  J. Grem.  The prognostic importance of tumor markers in adenocarcinomas of the gastrointestinal tract. , 1997, Current opinion in oncology.

[18]  Y. Maehara,et al.  Indicative value of carcinoembryonic antigen (CEA) for liver recurrence following curative resection of stage II and III gastric cancer. , 1996, Hepato-Gastroenterology.

[19]  Y. Ikeda,et al.  Prognostic value of combination assays for CEA and CA 19-9 in gastric cancer. , 1995, Oncology.

[20]  W. Yasui,et al.  Are Japanese and European gastric cancer the same biological entity? An immunohistochemical study. , 1995, British Journal of Cancer.

[21]  N. Nagasue,et al.  Clinicopathologic features and long-term results of alpha-fetoprotein-producing gastric cancer. , 1990, The American journal of gastroenterology.

[22]  O. Nilsson,et al.  Detection by monoclonal antibody of carbohydrate antigen CA 50 in serum of patients with carcinoma. , 1984, British medical journal.

[23]  M. Herlyn,et al.  Colorectal carcinoma antigens detected by hybridoma antibodies , 1979, Somatic cell genetics.

[24]  P. Gold,et al.  SPECIFIC CARCINOEMBRYONIC ANTIGENS OF THE HUMAN DIGESTIVE SYSTEM , 1965, The Journal of experimental medicine.

[25]  Abelev Gi,et al.  production Of Embryonal α-globulin By Transplantable Mouse Hepatomas , 1963 .

[26]  I. Irlin,et al.  PRODUCTION OF EMBRYONAL &agr;‐GLOBULIN BY TRANSPLANTABLE MOUSE HEPATOMAS , 1963, Transplantation.

[27]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[28]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[29]  G. Costa,et al.  The role of serum and gastric juice levels of carcinoembryonic antigen, CA19.9 and CA72.4 in patients with gastric cancer , 1998, Journal of Cancer Research and Clinical Oncology.

[30]  A. Norman,et al.  The prognostic value of serum and immunohistochemical tumour markers in advanced gastric cancer. , 1996, European journal of cancer.

[31]  D.,et al.  Regression Models and Life-Tables , 2022 .